Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 1
2021 1
2022 2
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis.
Li M, Yang L, Chan AKN, Pokharel SP, Liu Q, Mattson N, Xu X, Chang WH, Miyashita K, Singh P, Zhang L, Li M, Wu J, Wang J, Chen B, Chan LN, Lee J, Zhang XH, Rosen ST, Müschen M, Qi J, Chen J, Hiom K, Bishop AJR, Chen CW. Li M, et al. Adv Sci (Weinh). 2023 Jun;10(17):e2206584. doi: 10.1002/advs.202206584. Epub 2023 Apr 19. Adv Sci (Weinh). 2023. PMID: 37075745 Free PMC article.
Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.
Presant CA, Ashing K, Yeung S, Macalintal J, Tiep B, Sandoval A, Brown S, Cianfrocca M, Erhunmwunsee L, Raz D, Amini A, Salgia R, Fu P Jr, Merla A, Graves H, Pathak R, Dingal S, Tan T, Tarkeshian K, Nikolaenko L, Burns K, Sampath S, Laksana B, Gascon B, Tainatongo-Landin D, Degoma V, Subbiah S, Rai R, Rosen S. Presant CA, et al. Cancer Causes Control. 2023 Jan;34(1):81-88. doi: 10.1007/s10552-022-01619-1. Epub 2022 Oct 12. Cancer Causes Control. 2023. PMID: 36224501 Free PMC article. Review.
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
Aldoss I, Otoukesh S, Zhang J, Mokhtari S, Ngo D, Mojtahedzadeh M, Al Malki MM, Salhotra A, Ali H, Aribi A, Sandhu KS, Arslan S, Koller P, Ball B, Stewart F, Curtin P, Artz A, Nakamura R, Marcucci G, Forman SJ, Stein AS, Pullarkat V. Aldoss I, et al. Cancer. 2022 Feb 1;128(3):529-535. doi: 10.1002/cncr.33967. Epub 2021 Oct 11. Cancer. 2022. PMID: 34633671 Free article.